Physician profile
Sima Stein
NPI 1427134832
$1,401.51
in general payments reported to CMS, 2019-2025
17 companies · $255 in 2025
The $255 reported for 2025 was more than what 80% of Pediatrics providers received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $89.29 · 2020: $214 · 2021: $304 · 2022: $231 · 2023: $100 · 2024: $208 · 2025: $255.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $563.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $563.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $556.09 | 2019-2025 | |
| Sanofi-Aventis U.S. LLC | $123.08 | 2024-2025 | |
| Merck Sharp & Dohme LLC | $105.75 | 2021-2025 | Gardasil 9, Vaxneuvance, Vaxelis |
| Alk-Abello, INC | $93.29 | 2020-2023 | Odactra, Grastek |
| Seqirus USA INC | $81.75 | 2022-2025 | Flucelvax, Flucelvax Quadrivalent |
| Sanofi Pasteur INC. | $79.00 | 2019-2025 | |
| Astrazeneca Pharmaceuticals Lp | $76.89 | 2022-2025 | Fasenra |
| Cognoa, INC. | $71.97 | 2022 | |
| Kaleo, INC. | $56.69 | 2019-2021 | |
| Cranial Technologies, INC | $40.29 | 2020-2024 | Doc Band |
| Verrica Pharmaceuticals INC. | $22.54 | 2025 | Ycanth |
| Alexion Pharmaceuticals, INC. | $20.26 | 2021 | |
| Genzyme Corporation | $17.82 | 2024 | |
| Ultragenyx Pharmaceutical INC. | $17.06 | 2025 | Dojolvi |
| Ars Pharmaceuticals Operations, INC. | $13.52 | 2025 | Neffy |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Qiagen, LLC | $12.77 | 2021 | |
| Glaxosmithkline, LLC. | $12.74 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sima Stein listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.